Financial results

Recro to Report Year End 2019 Financial Results

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) a leading contract development and manufacturing organization (CDMO) with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug …

Read More